These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 25952368

  • 1. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
    Lv C, Zhou YH, Wu C, Shao Y, Lu CL, Wang QY.
    Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368
    [Abstract] [Full Text] [Related]

  • 2. Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.
    Shao Y, Ren H, Lv C, Ma X, Wu C, Wang Q.
    Endocrine; 2017 Jan; 55(1):130-138. PubMed ID: 27522360
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The Expression of miR-192 and Its Significance in Diabetic Nephropathy Patients with Different Urine Albumin Creatinine Ratio.
    Ma X, Lu C, Lv C, Wu C, Wang Q.
    J Diabetes Res; 2016 Jan; 2016():6789402. PubMed ID: 26881255
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC, Susanto H, Chuang WH, Liu TY, Wang CH.
    Cardiovasc Diabetol; 2016 Jan 07; 15():3. PubMed ID: 26739836
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios.
    Ren H, Shao Y, Ma X, Yang M, Liu Y, Wang Q.
    J Diabetes Complications; 2019 Jul 07; 33(7):477-484. PubMed ID: 31097304
    [Abstract] [Full Text] [Related]

  • 11. Amelioration of diabetic nephropathy in db/db mice treated with tibetan medicine formula Siwei Jianghuang Decoction Powder extract.
    Lai X, Tong D, Ai X, Wu J, Luo Y, Zuo F, Wei Z, Li Y, Huang W, Wang W, Jiang Q, Meng X, Zeng Y, Wang P.
    Sci Rep; 2018 Nov 12; 8(1):16707. PubMed ID: 30420600
    [Abstract] [Full Text] [Related]

  • 12. Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
    Qiao YC, Chen YL, Pan YH, Ling W, Tian F, Zhang XX, Zhao HL.
    Medicine (Baltimore); 2017 Apr 12; 96(15):e6583. PubMed ID: 28403088
    [Abstract] [Full Text] [Related]

  • 13. Estimation of transforming growth factor-beta 1 as a marker of renal injury in type II diabetes mellitus.
    Ibrahim S, Rashed L.
    Saudi Med J; 2007 Apr 12; 28(4):519-23. PubMed ID: 17457470
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Potential serum biomarkers for early detection of diabetic nephropathy.
    Motawi TK, Shehata NI, ElNokeety MM, El-Emady YF.
    Diabetes Res Clin Pract; 2018 Feb 12; 136():150-158. PubMed ID: 29253627
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of serum levels of sestrin 2 and betatrophin in type 2 diabetic patients with diabetic nephropathy.
    Emara AM, El Bendary AS, Ahmed LM, Okda HI.
    BMC Nephrol; 2024 Jul 19; 25(1):231. PubMed ID: 39030467
    [Abstract] [Full Text] [Related]

  • 17. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy.
    Khan S, Qayyum S, Khan MNA.
    J Pak Med Assoc; 2024 May 19; 74(5):862-867. PubMed ID: 38783431
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Endocan and albuminuria in type 2 diabetes mellitus.
    Cikrikcioglu MA, Erturk Z, Kilic E, Celik K, Ekinci I, Yasin Cetin AI, Ozkan T, Cetin G, Dae SA, Kazancioglu R, Erkoc R.
    Ren Fail; 2016 Nov 19; 38(10):1647-1653. PubMed ID: 27756187
    [Abstract] [Full Text] [Related]

  • 20. New risk factors in diabetic nephropathy: microRNA-196-3p and microRNA-203.
    Eroglu İ, Korkmaz H, Ozturk KH, Sirin FB, Sevik S, Afsar B.
    Minerva Endocrinol (Torino); 2022 Sep 19; 47(3):314-324. PubMed ID: 33331738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.